Summit Therapeutics, Inc. (SMMT)
Summit Therapeutics Market Cap : 12.02B for Feb. 23, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 990.83B |
| Exelixis, Inc. | 11.39B |
| Insmed, Inc. | 34.76B |
| Madrigal Pharmaceuticals, Inc. | 9.875B |
| Soleno Therapeutics, Inc. | 2.161B |
Market Cap Related Metrics
| PEG Ratio | -0.0373 |
| Price to Book Value | 62.50 |
| Price | 16.14 |
| Earnings Yield | -7.69% |
| PEGY Ratio | -0.0373 |